Compass Therapeutics, Inc. Common Stock (NASDAQ: CMPX) last traded at $0.993, up 0.98% on the session. The quote above updates while this page is open; the figures below are drawn from Compass Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Compass Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CMPX. Its market capitalisation is $178.83 million.
Valuation measures for Compass Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $178.83M |
|---|---|
| Enterprise value | $167.50M |
| Price / book | 1.08 |
| Beta | 1.41 |
Trailing-twelve-month figures tagged in Compass Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$73.45M |
|---|
| EPS (TTM) | -$0.390 |
|---|
| Return on equity | -44.23% |
|---|
| Cash | $35.45M |
|---|
Range and volume for CMPX over the past 52 weeks.
| 52-week high | $6.88 |
|---|---|
| 52-week low | $0.829 |
| Volume | 3.67M |
| Average volume | 4.14M |
| Previous close | $0.983 |
Invest a chosen dollar amount in Compass Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CMPX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.